Noctura 400 is a CE marked, MHRA registered medical device.

It has been evaluated within the NHS and has proven safety and efficacy for the prevention and treatment of diabetic retinopathy and diabetic macular oedema in adults.

Low-level light is used to reduce the retina’s oxygen demand during sleep and prevent hypoxia.

Noctura 400 is non invasive, does not disturb sleep and can be used on its own or as an adjunct to current treatments.

About

More

Company

Manufacturers Registered Address